Colgate-Palmolive Company (CL) COO Justin Skala Sells 126,393 Shares of Stock

Colgate-Palmolive Company (NYSE:CL) COO Justin Skala sold 126,393 shares of the company’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $72.97, for a total transaction of $9,222,897.21. Following the sale, the chief operating officer now owns 262,361 shares of the company’s stock, valued at $19,144,482.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Colgate-Palmolive Company (NYSE:CL) opened at $73.70 on Tuesday. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. The stock has a market cap of $64,286.08, a PE ratio of 25.51, a P/E/G ratio of 3.35 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The firm had revenue of $3.97 billion during the quarter, compared to analyst estimates of $3.94 billion. During the same quarter in the prior year, the business posted $0.73 earnings per share. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. analysts expect that Colgate-Palmolive Company will post 2.88 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, November 15th. Investors of record on Monday, October 23rd will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.17%. The ex-dividend date is Friday, October 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 61.78%.

TRADEMARK VIOLATION NOTICE: This article was originally posted by TrueBlueTribune and is the sole property of of TrueBlueTribune. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this article can be accessed at https://www.truebluetribune.com/2017/11/14/colgate-palmolive-company-cl-coo-justin-skala-sells-126393-shares-of-stock.html.

A number of research firms have issued reports on CL. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. Citigroup Inc. decreased their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating for the company in a report on Thursday, November 2nd. Morgan Stanley decreased their price target on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a report on Tuesday, October 31st. Jefferies Group LLC cut their price objective on shares of Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a research report on Monday, October 30th. Finally, Stifel Nicolaus set a $73.00 price objective on shares of Colgate-Palmolive and gave the company a “hold” rating in a research report on Sunday, October 29th. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and four have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $76.67.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Colgate-Palmolive by 2.4% during the second quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after buying an additional 1,621,392 shares in the last quarter. Renaissance Technologies LLC increased its holdings in shares of Colgate-Palmolive by 42.4% during the second quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after buying an additional 2,903,800 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Colgate-Palmolive by 25.3% during the second quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after buying an additional 1,385,946 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in shares of Colgate-Palmolive by 35.8% during the third quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after buying an additional 1,750,417 shares in the last quarter. Finally, Harding Loevner LP increased its holdings in shares of Colgate-Palmolive by 92.0% during the third quarter. Harding Loevner LP now owns 4,742,752 shares of the company’s stock worth $176,329,000 after buying an additional 2,272,675 shares in the last quarter. 73.87% of the stock is owned by institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply